Nf2 Biosolutions

990 • Fiscal year 2019 • EIN 83-0940046

Jan 01, 2019 to Dec 31, 2019

Organization Profile www.nf2biosolutions.org

West Chester, PA

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

54%

Higher net margin than 93% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

No value available

This filing does not contain officer compensation rows.

Source year 2019

200%

Faster asset growth than 95% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Annualized from 2018 to 2019

247%

Faster revenue growth than 97% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Annualized from 2018 to 2019

Balance Sheet

Liabilities / Assets55th percentile

Assets

$365,085

Up $243,483 (+200%) from 2018

Net Assets

$365,085

Up $243,483 (+200%) from 2018

Liabilities

Flat

Flat from 2018

Revenue And Expenses

Liabilities / Revenue55th percentile Net Margin93rd percentile

Revenue

$449,651

Up $320,212 (+247%) from 2018

Expenses

$206,168

Up $198,331 (+2531%) from 2018

Net Income

$243,483

Up $121,881 (+100%) from 2018

Historical Trend

Balance Sheet Trend

Asset Growth95th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

Highlighted filing

2019

Assets$365,085

Liabilities$0

Net Assets$365,085

Open 2019 Filing

Operations Trend

Revenue Growth97th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

Highlighted filing

2019

Revenue$449,651

Expenses$206,168

Net Income$243,483

Open 2019 Filing

Filing Detail Status

This 2019 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

View Latest Detailed Filing (2024)

Jump To

Filing Snapshot

Filing Period: Jan 1, 2019 to Dec 31, 2019

Mission and Program Overview

Mission

Seeking a cure or preventative treatment for NF2 by vigorously supporting and advancing existing and next generation biomedical technologies such as gene transfer therapy and immunontherapy

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2019 • Form 990Summary only. Only limited summary data is available for this year.

Open filing

Assets: $365,085
Liabilities: $0
Net assets: $365,085
Revenue: $449,651
Expenses: $206,168
Net income: $243,483

	Balance Sheet			Operations
Year	Assets	Liabilities	Net Assets	Revenue	Expenses	Net Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.	$6.22	$1.02	$5.20	$2.26	$3.17	$0.91
2023Summary only. Only limited summary data is available for this year.	$7.12	$1.02	$6.10	$7.72	$9.66	$1.94
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.	$9.06	$1.02	$8.05	$4.19	$3.08	$1.10
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.	$7.96	$1.02	$6.94	$5.44	$3.86	$1.58
2020Summary only. Only limited summary data is available for this year.	$6.38	$1.02	$5.36	$7.08	$5.37	$1.71
2019Summary only. Only limited summary data is available for this year.	$3.65	$0.00	$3.65	$4.50	$2.06	$2.43
2018Summary only. Only limited summary data is available for this year.	$1.22	$0.00	$1.22	$1.29	$0.08	$1.22